Presidential tip: Pharmacists must take the lead
Managed care pharmacists have the potential to lead pharmaceutical care into the millennium, according to the new president of the Academy of Managed Care Physicians.
Managed care pharmacists have the potential to lead pharmaceutical care into the millennium, according to the new president of the Academy of Managed Care Physicians.
During his inaugural speech at the AMCP's annual meeting in New Orleans in May, Lowell Sterler emphasized that pharmacists can't rely on familiarity of the past and must instead embrace the future. In order to propel the profession beyond its traditional boundaries, "[pharmacists] must be visionary, not reactionary," he said.
Sterler made four recommendations that showed how managed care pharmacists could be more active leaders.
•Â "We must document what we do in our profession, how we make our decisions and the impact of those decisions on both patients and the organizations we serve. That will show definitely that what we do results in good, and often improved, outcomes in our patients."
•Â "We must show that increases in pharmaceutical costs can lead to reductions in hospitalizations and other medical services. As managed care pharmacists who put patients first, we must not be held hostage to a notion that success comes from managing pharmacy in a vacuum."
•Â "We must continue to make our voices heard strong and clear on the legislative and regulatory front."
•Â "We must reach out to the next generation of pharmacists to prepare them for how pharmacy will be practiced in the years to come."
For a complete copy of Sterler's speech, contact the AMCP, (800) 827-2627.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
